Osteopontin directly modulates cytokine expression of primary microglia and increases their survival

Monika Rabenstein1, Sabine Ulrike Vay1, Lea Jessica Flitsch1

  • 1Department of Neurology, University Hospital of Cologne, Cologne, Germany.

Insights

Osteopontin (OPN) enhances microglia survival and reduces inflammatory responses, suggesting a neuroprotective role in brain injury. OPN shifts microglia towards a neutral, anti-inflammatory phenotype.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Osteopontin (OPN) is present in the brain and increases during neuroinflammation like focal cerebral ischemia.
  • OPN deficiency in mice leads to deregulated microglia after ischemia, but OPN's specific effects on microglia are not fully understood.

Purpose of the Study:

  • To investigate the direct effects of Osteopontin (OPN) on primary microglia function.
  • To determine if OPN influences microglia survival and inflammatory responses.

Main Methods:

  • Primary microglia cultures were established.
  • Cultures were treated with or without Osteopontin (OPN).
  • Microglia were subjected to stress conditions and lipopolysaccharide (LPS) stimulation to assess inflammatory markers.

Main Results:

  • Osteopontin (OPN) dose-dependently increased microglia survival under stress.
  • OPN significantly attenuated lipopolysaccharide (LPS)-induced release of nitric oxide (NO), TNF-α, and IL-6.
  • OPN reduced the expression of inducible Nitric Oxide Synthase (iNOS) in microglia.

Conclusions:

  • Osteopontin (OPN) plays a crucial role in modulating microglia function.
  • OPN promotes microglia survival and suppresses inflammatory mediator production.
  • Data indicate OPN shifts microglia towards a neutral, anti-inflammatory phenotype, suggesting potential therapeutic applications in neuroinflammation.

Related Concept Videos